The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
The acquisitions merge DatCard and Sorna’s expertise in clinical data sharing with Avandra’s de-identified patient data aggregation platform
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
Roche says the move marks a step forward in its digital transformation strategy
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
Subscribe To Our Newsletter & Stay Updated
